Display options
Share it on

Prz Gastroenterol. 2016;11(3):145-149. doi: 10.5114/pg.2016.61492. Epub 2016 Jul 27.

Alternative staging of regional lymph nodes in gastric cancer.

Przeglad gastroenterologiczny

Antoni M Szczepanik, Agata Paszko, Miroslaw Szura, Thecla Scully-Horner, Jan Kulig

Affiliations

  1. 1 Department of General, Gastrointestinal, and Oncologic Surgery, Jagiellonian University Medical College, Krakow, Poland.
  2. Intensive Care Unit, Queen Alexandra Hospital, Portsmouth, United Kingdom.

PMID: 27713774 PMCID: PMC5047974 DOI: 10.5114/pg.2016.61492

Abstract

The TNM pN stage based on the number of metastatic lymph nodes is an independent prognostic factor in gastric cancer. Many studies have highlighted the phenomenon of stage migration and problems in comparing groups of patients with different numbers of total lymph nodes harvested within TNM staging. The current version of UICC/AJCC and JGCA TNM classifications postulates a minimal number of 16 lymph nodes as the base for N stage determination. Alternative systems such as lymph node ratio (LNR), positive to negative lymph node ratio (PNLNR), and LOGODDS (or LODDS), were implemented to increase the quality of LN assessment. These methods have reached the background in the literature, but to date no standard approach according to the cut-offs for the stages has been implemented. LOGODDS is the method that most reflects the number of harvested lymph nodes. The rationale for alternative staging methods, their correlations, and limitations are presented.

Keywords: gastric cancer; lymph node staging; lymphadenectomy

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. World J Gastroenterol. 2010 Apr 28;16(16):2055-60 - PubMed
  2. BMC Cancer. 2007 Oct 24;7:200 - PubMed
  3. World J Surg. 2005 Dec;29(12):1576-84 - PubMed
  4. PLoS One. 2012;7(2):e31736 - PubMed
  5. Eur J Surg Oncol. 2011 Jun;37(6):488-96 - PubMed
  6. J Gastrointest Surg. 2007 Apr;11(4):410-9; discussion 419-20 - PubMed
  7. World J Gastroenterol. 2013 Mar 28;19(12):1975-83 - PubMed
  8. World J Surg. 2012 May;36(5):1096-101 - PubMed
  9. Cancer. 2010 Jun 1;116(11):2571-80 - PubMed
  10. N Engl J Med. 1985 Jun 20;312(25):1604-8 - PubMed
  11. World J Surg. 2010 Jan;34(1):85-91 - PubMed
  12. Ann Oncol. 2010 May;21 Suppl 5:v50-4 - PubMed
  13. Am Surg. 2007 Apr;73(4):359-66 - PubMed
  14. Gastric Cancer. 2011 Jun;14(2):101-12 - PubMed
  15. Prz Gastroenterol. 2014;9(6):325-8 - PubMed
  16. Ann Surg Oncol. 2002 Apr;9(3):278-86 - PubMed
  17. Ann Surg. 2012 Mar;255(3):478-85 - PubMed
  18. Br J Surg. 1996 Nov;83(11):1600-3 - PubMed
  19. PLoS One. 2012;7(6):e38681 - PubMed
  20. Br J Surg. 2009 Aug;96(8):910-8 - PubMed
  21. J Gastric Cancer. 2011 Jun;11(2):86-93 - PubMed
  22. Ann Surg. 2012 Jan;255(1):50-8 - PubMed
  23. Anticancer Res. 2012 May;32(5):1839-42 - PubMed
  24. Int J Cancer. 2013 Mar 1;132(5):1156-61 - PubMed
  25. J Clin Oncol. 2012 Nov 1;30(31):3834-40 - PubMed
  26. Am J Surg. 2007 Jan;193(1):10-5 - PubMed
  27. Eur J Surg Oncol. 2012 Jun;38(6):497-502 - PubMed
  28. J Clin Oncol. 2005 Oct 1;23(28):7114-24 - PubMed

Publication Types